Related Experiment Video
Updated: Nov 27, 2025

Isolation and Culturing of Primary Murine Adipocytes from Lean and Obese Mice
Published on: January 24, 2025
Visceral Adiposity Elevates the Risk of Critical Condition in COVID-19: A Systematic Review and Meta-Analysis
Mária Földi1,2,3, Nelli Farkas1,4, Szabolcs Kiss1,2,3
1Institute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary.
Insights
Higher visceral fat area (VFA) is linked to critical COVID-19 outcomes. This study found increased VFA in patients needing intensive care or mechanical ventilation, highlighting abdominal adiposity as a significant risk factor.
Area of Science:
- Medical research
- Public health
- Epidemiology
Background:
- Higher Body Mass Index (BMI) is a known risk factor for severe COVID-19.
- Body composition, specifically visceral adiposity, may offer more accurate patient stratification than BMI alone.
Purpose of the Study:
- To evaluate the association between computed-tomography-quantified fat mass distribution and critical COVID-19 outcomes.
- To determine if visceral fat area (VFA) can predict severe disease in COVID-19 patients.
Main Methods:
- Systematic literature search across five databases up to November 17, 2020.
- Meta-analysis of pooled mean differences (SMD) in VFA between intensive care unit (ICU) patients and general ward patients.
- Meta-analysis of pooled mean differences (SMD) in VFA between patients requiring invasive mechanical ventilation (IMV) and those not.
Main Results:
- Patients in the ICU had significantly higher VFA compared to those on the general ward (SMD = 0.46, P < 0.001).
- Patients requiring IMV also showed significantly higher VFA compared to those without IMV (SMD = 0.38, P = 0.026).
Conclusions:
- Visceral fat area (VFA) is significantly higher in patients with critical COVID-19 conditions.
- Abdominal adiposity, indicated by VFA, appears to be a risk factor for severe COVID-19.
- Patients with central obesity may require closer monitoring and specialized attention during the COVID-19 pandemic.
Objective:
A higher BMI has become acknowledged as one of the important risk factors for developing critical condition in coronavirus disease 2019 (COVID-19). In addition to BMI, body composition, and particularly visceral adiposity, might be an even more accurate measure to stratify patients. Therefore, the aim of this study was to evaluate the association between the distributions of computed-tomography-quantified fat mass and critical condition of patients with COVID-19.
Methods:
A systematic search was conducted in five databases for studies published until November 17, 2020. In the meta-analysis, pooled mean difference (standardized mean difference [SMD]) of visceral fat area (VFA; in square centimeters) was calculated between patients in the intensive care unit and those in general ward and between patients with the requirement for invasive mechanical ventilation (IMV) and those without the IMV requirement.
Results:
The quantitative synthesis revealed that patients requiring intensive care had higher VFA values (SMD = 0.46, 95% CI: 0.20-0.71, P < 0.001) compared with patients on the general ward. Similarly, patients requiring IMV had higher VFA values (SMD = 0.38, 95% CI: 0.05-0.71, P = 0.026) compared with patients without the IMV requirement.
Conclusions:
VFA values were found to be significantly higher in patients with critical condition. Therefore, abdominal adiposity seems to be a risk factor in COVID-19, and patients with central obesity might need special attention.
More Related Videos
06:22Isolation of Viable Adipocytes and Stromal Vascular Fraction from Human Visceral Adipose Tissue Suitable for RNA Analysis and Macrophage Phenotyping
Published on: October 27, 2020
07:24Assessment of Human Adipose Tissue Microvascular Function Using Videomicroscopy
Published on: September 29, 2017
Related Concept Videos
Obesity
Coronary Artery Disease I: Introduction
Cholesterol: Significance and Regulation
Considering cholesterol and...
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...